"Insulin Detemir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
| Descriptor ID |
D000069057
|
| MeSH Number(s) |
D06.472.699.587.200.300.050 D12.644.548.586.200.300.050
|
| Concept/Terms |
Insulin Detemir- Insulin Detemir
- Detemir, Insulin
- Basal Insulin Detemir
- Detemir, Basal Insulin
- Insulin Detemir, Basal
B29-tetradecanoyl-Lys-B30-des-Ala-insulin- B29-tetradecanoyl-Lys-B30-des-Ala-insulin
- B29 tetradecanoyl Lys B30 des Ala insulin
- Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)
- 12C-Lys(B29)-DB30I
- Des-(B30)-insulin, Lys(B29)-tetradecanoyl
- Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)
|
Below are MeSH descriptors whose meaning is more general than "Insulin Detemir".
Below are MeSH descriptors whose meaning is more specific than "Insulin Detemir".
This graph shows the total number of publications written about "Insulin Detemir" by people in this website by year, and whether "Insulin Detemir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Detemir" by people in Profiles.
-
An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial. Diab Vasc Dis Res. 2017 07; 14(4):336-344.
-
Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes. Diabet Med. 2016 Apr; 33(4):506-10.